juan shou yu
wang yong jun

..............page:905

Effect of total flavonoids from scutellarea baicalensis stem-leaf on hippocampal injury induced by bilateral injection of Aβ25-35 in rats
wang rui-ting1; shen xing-bin2; zhou jian1; guan li-hua1; zhang jian-xin3(1 chengde medical college; chengde 067000; china; 2 affilited hospital of chengde medical college; chengde 067000; china; 3 insitute meteria medica; hebei academy of medical sciences; shijiazhuang 050021; china)

..............page:982-985

Advances in pharmaceutical research of basic fibroblast growth factor
zeng huan-xiang1; zhang hong-bo1; huang kai1; xiang qi2(1 r&d center; shenzhen zhijun pharmaceutical co.; ltd.; shenzhen 518110; china; 2 biopharmaceutical r&d center of jinan university; guangzhou 510632; china)

..............page:949-952

Pharmacology and clinical evaluation of fospropofol disodium
zhu feng1; shi ai-xin2; fu de-xing2(1 department of healthcare; general staff guard bureau; beijing 100017; china; 2 department of pharmacy; beijing hospital; beijing 100730; china)

..............page:914-916

Discussion on the standardization for the clinical trials of drug therapy for cerebral infarction
shi jin; hu wen-juan(department of neurology; general hospital of air force; beijing 100036; china)

..............page:917-920,936

Effect of Huishengzaizao bolus in rat model of Parkinson's disease
kan hong-wei1; wei an-xiang2; bao guang-li3; liang yan1; xu peng-fu1; yang shi-you1(1 anhui institute of materia medica; anhui province key laboratory of traditional chinese medicine research and development; hefei 230022; china; 2 school of life science; anhui university; hefei 230039; china; 3 dong zhi tang pharmaceutical anhui co.; ltd.; huainan 232001; china)

..............page:979-981,998

One-year observation of smoking cessation efficacy of topiramate in patients with depression
zhang hong-mei; liang wei; chen zuo-ming(department of clinical psychology; the second affiliated hospital of xinxiang medical college; xinxiang 453002; china)

..............page:966-969

Neuroprotective effect of ceftriaxone sodium on focal cerebral ischemia in rats and the mechanism
zhang zhuang1; min lian-qiu1; xia dong-jian2(1 department of neurology; 2 department of neurosurgery; first affiliated hospital; liaoning medical college; jinzhou 121001; china)

..............page:975-978

Prospective study on treatment of acute progressive cerebral infarction with Dengzhan Shengmai capsule
mao de-jun1; gong xiang-cong2; tang yong-chun1; guo rui-you1(1 department of neurology; the affiliated hiser medical group of qingdao university medical college; qingdao 266033; china; 2 department of internal medicine; lanchun cerntral hospital of jimo of qingdao; jimo 266232; china)

..............page:959-962

zhong guo xin yao za zhi di si jie bian wei hui di er ci hui yi zuo di yi jie zhong guo yi yuan yao xue ( bei hai ) lun tan yu tong zhi

..............page:903

Role of oxidative stress on Alzheimer's disease and research advance of new drugs
chu ben-hong; dong wen-xin(shanghai institute of pharmaceutical industry; shanghai 200437; china)

..............page:940-943,948

Key problems in the development of innovative drugs——scientific rationale and principle requirement of clinical studies
wang shui-qiang(center for drug evaluation; state food and drug administration; beijing 100038; china)

..............page:930-932

2010 nian zhong guo xin yao za zhi zhuan xiang jian jie

..............page:901

Efficacy of thrombolysis by intravenous recombinant tissue plasminogen activator in hyperacute cerebral infarction
li hao-jun; liu ming; shen sa; liu hong; pan shu-ming(department of emergency of xinhua hospital affiliated to school of medicine; shanghai jiaotong university; shanghai 200092; china)

..............page:953-955

Development and marketing strategies of me too drug
su wei-ping1; 2; hu hao1; shi lu-wen2; 3; wang yi-tao1; 3(1 institute of chinese medical sciences; university of macau; macau; china; 2 department of pharmacy administration and clinical pharmacy; school of pharmaceutical sciences; peking university; beijing 100191; china; 3 international research center for medicinal administration; peking university; beijing 100191; china)

..............page:926-929

Construction of complementary systems relative to registration of generics
zhang ning1; 2; ping qi-neng1(1 college of international pharmacy and business; china pharmaceutical university; nanjing 210009; china; 2 center for drug evaluation; state food and drug administration; beijing 100038; china)

..............page:921-925

Case analysis on severe hyponatremia induced by hypophysin
ma chao1; 2; qi xiao-lian1(1 department of pharmacy; xuanwu hospital; the capital medical university; beijing 100053; china; 2 department of pharmacy; bejing fengtai hospital; bejing 100071; china)

..............page:995-998

Antidepressant therapy in functional gastrointestinal disorders
han mai; duan li-ping(department of gastroenterology; third hospital; peking university; beijing 100191; china)

..............page:944-948

WINDOW OF NEW DRUGS

..............page:912-913

Protective effect of Naoshu capsule on neuroinflammatory injury in rat model of Alzheimer's disease
qin da-lian1; yue yong-hua1; tian ji2; zhang zhuo1; liu jian1; li hua1; gu li1(1 department of pharmacology; 2 institute of materia medica; luzhou medical college; luzhou 646000; china)

..............page:986-990

Quality assurance and field inspection of genetic toxicity tests
guo qiao-zhen; wu chun-qi; ma hua-zhi; liao ming-yang; ding ri-gao(institute of toxicology and pharmacology; academy of military medical sciences; national beijing center for drug safety evaluation and research; beijing 100850; china)

..............page:937-939

di yi jie zhong guo nao xue guan bing chuang xin yao wu chan ye lian meng gao feng lun tan tong zhi

..............page:902

Clinical study of Shuxuening injection for treating patients with acute cerebral infarction
du xian-lan1; li yan-bin1; li dan1; li bao-zhu1; xu cai-mian1; tang ping2(1 beijing hepingli hospital; beijing 100013; china; 2 the first people s hospital of chengdu city; chengdu 610016; china)

..............page:963-965

Effect of baicalin on the brain expression of GAT-1 and GABA_AR after intracerebral hemorrhage in rats
zhao yan-mei; yu si-ming; zhou qian-kun(school of life science; key laboratory of traditional chinese medicine research and development of anhui university; hefei 230039; china)

..............page:970-974

zhong guo xin yao za zhi tou gao xu zhi

..............page:999-1000

duan xun

..............page:916,955,974,990

Cost-effectiveness analysis of 6 Chinese traditional medicine injections for treating acute cerebral infarction
ma ying1; jin xue-ting2(1 department of pharmacy; first hospital of tianjin university of tcm; tianjin 300193; china; 2 department of pharmacy; tianjin central hospital of obstetrics and gynecology; tianjin 300180; china)

..............page:991-994

zhi liang kong zhi yu ke ji chuang xin shi fa zhan xian dai zhong yao de he xin zhong guo xin yao za zhi zhuan fang shen wei yao ye dong shi chang li zhen jiang

..............page:909-911

Selection,characterization and evaluation for the key technologies in the "key new drug creation and development programme"
sun yu; gao bo; xu shou-jun; wei xiao-qing; zhang yong-xiang(ministry of science and technology; academy of military medical science; beijing 100850; china)

..............page:933-936

jian li chuang xin yao wu chan ye lian meng , tui dong nao xue guan bing yao wu chuang xin zhong guo xin yao za zhi zhuan fang wang yong jun jiao shou

..............page:906-908

Effect of atorvastatin on blood lipid and its safety in preventing ischemic stroke
xie jian; zhang cheng-guo(department of neurology; the first people s hospital of foshan; foshan 528000; china)

..............page:956-958,969

ben qi dao du

..............page:898